Niveles de células progenitoras endoteliales circulantes en pacientes hipertensos tratados

Despite an optimal treatment, hypertensive patients show a decreased number of circulating EPCs that could be, at least in part, responsible for their residual cardiovascular risk, suggesting that these cells could be a therapeutic target.